Fritextsökning
Innehållstyper
-
SMC lanserar robust 2-portsventil med pilotstyrning
Nya JSXD från SMC är en IP67-klassad, pilotstyrd magnetventil för av/på- applikationer. Flera olika tätningsmaterial gör ventilen lämplig för ett stort antal pr...
-
“We need to keep investing in research and innovation”
Jenni Nordborg has worked for just over four years to highlight life science in Sweden. Her mandate as national coordinator ends in December 2022. ““Life scienc...
-
Anders Blanck about his 17 years at Lif: “The industry is enjoying greater public trust now"
The announcement came as a surprise to those around him, but according to the protagonist himself, the timing was excellent. Anders Blanck is now leaving Lif – ...
-
Han tar över som ordförande i CTR
Bengt Dahlström, grundare av Center for Translational Research, har efter sju år som styrelseordförande i koncernen lämnat över ordförandeklubban till Hans Andreasson.
-
Webinar: Clinical evaluation and clinical investigation of medical devices
Whether you are a small medtech company or a large one, this webinar is a must-attend for anyone curious about how clinical studies on medical devices are conducted.
-
Amorphous materials take centre stage when Orexo develops new formulations
Swift resolution but with maintained stability. Orexo’s new drug delivery platform tackles the problem of amorphous materials. “Our technology has the positive ...
-
SMC breddar sortimentet för cobots
Den här gången är det vårt kompletta allt-i-ett vakuumgripdon ZXP7 samt kompakta, pneumatiska gripdonet JMHZ2 med mycket låg vikt, som släpps i utförande för Kawasakis cobots.
-
Webinar: Medtech quality and regulatory compliance
This webinar is for you who are developing or planning to develop a medical device, combination, or borderline product. In one hour, we will discuss what you ne...
-
Stockholm aims at becoming one of the world’s top life science regions
Regional Chair for Finance, Irene Svenonius (M), believes that Stockholm can realise the goal of becoming one of the world’s top 5 regions in life science by 20...
-
Tougher competition as the Novo Nordisk Foundation broadens its programme
Søren Nedergaard has worked with innovation at the Danish Government Offices and the University of Copenhagen. Today, he is COO of the Novo Nordisk Foundation, ...
-
Ett vaccin som världen väntar på: ”Kan ändra livet för många”
I ett laboratorium i Solna utvecklas ett vaccin som, om allt går i lås, kan rädda otaliga barns liv i låg- och medelinkomstländer. ”Det är viktigt för mig att j...
-
Novo Nordisk buys drug candidate in billion dollar deal
The Danish pharmaceutical giant Novo Nordisk have made an agreement with KBP Biosciences to aqcuire the hypertension drug ocedurenone for up to 1.3 billion doll...
-
Anna Törner: Kalashnikovs in a new guise
Thanks to resisting European regulatory authorities, Europe has been spared the opioid epidemic. In the 1960s, the situation was the opposite as the American ph...
-
Novo Nordisk accepterar förhandlade Medicare-priser för fetmaläkemedel
Novo Nordisk har ingått ett prisavtal med USA gällande läkemedelsprogrammet Medicare. Det uppger bolaget i sin delårsrapport.
-
Hello Jenni Nordborg!
Life Science Sweden would like to know more about Jenni Nordborg and asks her about her new job, why she became a chemical engineer and who her role model is.
-
Optimism på Xspray efter uppgörelse i patenttvist
En uppgörelse uppges ha nåtts i patenttvisten mellan svenska forskningsbolaget Xspray Pharma och läkemedelsjätten Bristol Myers Squibb (BMS) om cancerkandidaten Dasynoc.
-
CAR-T therapies give continued hope: “Almost half of the patients have become disease-free”
When the first CAR-T therapies appeared, hopes were raised for the effective treatment for critically ill cancer patients. After a somewhat sluggish start, abou...
-
Business Sweden’s new team is rolling out the blue-yellow carpet
According to Business Sweden’s life science team, the combination of substantial medical know-how and an ever-flourishing tech sector is a success factor for Sw...
-
Crispr-bolag pausar studier efter rapport om allvarliga biverkningar
En allvarlig leverpåverkan hos en patient gör att amerikanska Intellia Therapeutics nu stoppar behandling och rekrytering i fas 3-studier med företagets genterapi.
-
Uppgifter: Amerikanskt företag vill förvärva Sobi
Det amerikanska riskkapitalbolaget Advent International överväger att lägga ett bud på svenska Sobi, enligt uppgifter.
-
Precision medicine centre: “Extensive activity on several fronts”
Two years ago, the Karolinska Institutet and the Karolinska University Hospital announced that they would jointly launch the Precision Medicine Centre. Medtech ...
-
Marie Gårdmark: Finally, it’s time for a revision of the EU pharma legislation
A challenge for the EU Commission is to deliver a new framework that will also take care of another “pillar” of the pharmaceutical strategy, namely, to ensure that new medicines will be available for all citizens in Europe, writes Marie Gårdmark...
-
Beslut idag: 17 innovationsprojekt får finansiering
I tuff konkurrens har 17 nya innovationsprojekt inom life science valts ut och får finansiering via Medtech4health och Swelife.
-
Bought a tablet factory – and built his own empire
In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move i...
BREAKING